Conspectus
As a monolayer version of nanoscale metal organic
frameworks (nMOFs),
nanoscale metal–organic layers (nMOLs) have recently emerged
as a novel class of two-dimensional (2D) molecular nanomaterials.
nMOLs are built from metal-oxo secondary building units (SBUs) with
suitable coordination modes and organic linkers with proper geometries
in a bottom-up fashion by carefully controlling the reaction temperature,
capping agents, water concentration, and other parameters. M6-BTB and related nMOLs are formed by linking M6(μ3-O)4(μ3-OH)4 (M = Zr4+, Hf4+, Ce4+) SBUs and planar tricarboxylate
bridging ligands such as 1,3,5-benzene-tribenzoate (BTB), while M12-nMOLs are constructed from M12(μ3-O)8(μ3-OH)8 (μ2-OH)6 (M = Zr4+, Hf4+) SBUs
and linear dicarboxylate ligands such as 5,15-di(p-benzoato)porphyrin (DBP). Mechanistic studies revealed the
important roles of capping agents and water on the growth of nMOLs
and the stepwise growth process involving the partial hydrolysis of
metal ions to form metal-oxo clusters with capping agents and the
subsequent replacement of capping agents by bridging ligands. The
2D nature of nMOLs facilitates the postsynthetic modification of bridging
ligands and the exchange of capping agents to simultaneously incorporate
multifunctionalities into nMOLs.
In this Account,
we discuss the design principles, growth mechanisms,
and postsynthetic functionalization strategies for nMOLs and summarize
our research efforts to design nMOLs for various biological and biomedical
applications. We first outline the strategies for the design and synthesis
of M6- and M12-nMOLs via a dimensional reduction
strategy and discuss the growth mechanisms of nMOLs. We then highlight
the methods for the postsynthetic functionalization of nMOLs. We demonstrate
the application of nMOLs in two broad categories. We first show the
design and development of nMOLs for radiotherapy–radiodynamic
therapy (RT–RDT) and further combination with checkpoint blockade
immunotherapy. The evolution of Hf6-nMOLs to Hf12-nMOLs illustrates the control of nMOL morphology and photosensitizer
loading for optimal RT–RDT effects. The nMOL-mediated RT–RDT
is further combined with checkpoint blockade cancer immunotherapy
to enable the treatment of systemic diseases via local X-ray irradiation.
We next demonstrate nMOLs as a versatile platform for ratiometric
sensing/imaging and drug delivery. The easily accessible sites on
SBUs and ligands in nMOLs provide conjugation sites for multifunctional
sensors and drugs, allowing for simultaneous ratiometric sensing of
the pH and oxygen concentration or pH and glutathione concentration
in mitochondria as well as highly effective photodynamic therapy with
insoluble conjugated zinc phthalocyanine.
We discuss the limitations
of currently available nMOLs in terms
of a lack of structural diversity and lower stability compared to
nMOFs. We also point out the untapped potential of using the inherent
hierarchy of SBU and bridging ligand structures to integrate multiple
functionalities for synergistic func...